french-nuclear-safety.fr/dosimetric-references EMERGENCY TREATMENT Deferoxamine PRESENTATION DESFERAL® 500 mg. Powder and solvent for injectable solution.. DOSAGE IV administration by continuous infusion at the recommended rate of 15 mg/kg/h, for 4-6 h. The total IV dose must not exceed 80 mg/kg/24 h. This medication can be used for adults and children. When used in children, their growth and weight shall be checked regularly. CONTRAINDICATIONS ▖Pregnancy. ▖Severe renal impairment. PHYSICAL CHARACTERISTICS Aluminium-26 ( 26Al ) ▖Radioactive half-life: 7.2• 105 years ▖Main types of radiation emitted: b+ and g SOURCES OF EXPOSURE ▖Nuclear reactors (activation of stable aluminium) 26 Al Aluminium EXPOSURE RISK ▖Irradiation ++ ▖External contamination ++ ▖Internal contamination ++ INTERNAL CONTAMINATION MEASUREMENT J Urine bioassay J Faeces bioassay J In vivo measurement Aluminium DOSE COEFFICIENT REFERENCE Effective committed dose per becquerel incorporated, taken from the Order mentioned in Article R. 1333-24 of the Public Health Code: RADIONUCLIDE HANDBOOK • Emergency treatment of internal contamination RH 3
RkJQdWJsaXNoZXIy NjQ0NzU=